HASTINGS PAUL J
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to HASTINGS PAUL J. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NKTX | Chief Executive Officer | Sale | 1,790 | $1.79 | $3,204 | Jun 18, 2025 |
| NKTX | Chief Executive Officer | Sale | 17,378 | $2.20 | $38,232 | Jan 15, 2025 |
| NKTX | Chief Executive Officer | Award / Grant | 94,500 | — | — | Jan 3, 2025 |
| NKTX | Chief Executive Officer | Sale | 1,770 | $5.60 | $9,912 | Jun 18, 2024 |
| PCRX | Sale | 880 | $28.38 | $24,974 | Jun 12, 2024 | |
| NKTX | Chief Executive Officer | Disposition | 12,358 | $13.00 | $160,654 | Mar 4, 2024 |
| NKTX | Chief Executive Officer | Sale | 9,697 | $8.74 | $84,752 | Jan 16, 2024 |
| NKTX | Chief Executive Officer | Award / Grant | 85,000 | — | — | Jan 4, 2024 |
| NKTX | Chief Executive Officer | Sale | 1,704 | $4.85 | $8,264 | Jun 20, 2023 |
| PCRX | Award / Grant | 1,775 | — | — | Jun 14, 2023 | |
| PCRX | Sale | 580 | $38.34 | $22,237 | Jun 5, 2023 | |
| PCRX | Sale | 7,000 | $41.85 | $292,950 | May 15, 2023 | |
| NKTX | Chief Executive Officer | Award / Grant | 64,500 | — | — | Jan 17, 2023 |
| NKTX | Chief Executive Officer | Sale | 23,376 | $13.03 | $304,589 | Sep 29, 2022 |
| NKTX | Chief Executive Officer | Sale | 6,126 | $13.01 | $79,699 | Sep 21, 2022 |
| PCRX | Sale | 533 | $56.95 | $30,354 | Jul 11, 2022 | |
| NKTX | Chief Executive Officer | Award / Grant | 19,500 | — | — | Jun 17, 2022 |
| PCRX | Award / Grant | 1,160 | — | — | Jun 8, 2022 | |
| NKTX | Chief Executive Officer | Award / Grant | 41,900 | — | — | Jan 14, 2022 |
| NKTX | Chief Executive Officer | Sale | 223 | $26.53 | $5,916 | Sep 29, 2021 |
| NKTX | Chief Executive Officer | Sale | 3,807 | $26.89 | $102,370 | Jun 21, 2021 |
| PCRX | Award / Grant | 1,066 | — | — | Jun 9, 2021 | |
| PCRX | Sale | 630 | $62.19 | $39,180 | Jun 4, 2021 | |
| NKTX | Chief Executive Officer | Sale | 3,130 | $32.21 | $100,817 | Mar 30, 2021 |
| PCRX | Sale | 3,000 | $65.88 | $197,640 | Mar 5, 2021 | |
| PCRX | Award / Grant | 1,260 | — | — | Jun 9, 2020 | |
| PCRX | Sale | 2,025 | $47.46 | $96,107 | Jun 4, 2020 | |
| PCRX | Award / Grant | 4,134 | — | — | Jun 4, 2019 | |
| PCRX | Award / Grant | 782 | — | — | Jun 13, 2018 | |
| PCRX | Sale | 771 | $33.90 | $26,137 | Jun 4, 2018 | |
| 0001302573 | Chairman & CEO | Sale | 1,346 | $4.24 | $5,707 | Oct 10, 2017 |
| PCRX | Sale | 1,044 | $36.15 | $37,741 | Aug 22, 2017 | |
| PCRX | Award / Grant | 1,357 | — | — | Jun 14, 2017 | |
| 0001302573 | Chairman & CEO | Award / Grant | 45,000 | — | — | Apr 24, 2017 |
| 0001302573 | Chairman & CEO | Sale | 48 | $8.87 | $426 | Apr 4, 2017 |
| 0001302573 | Chairman & CEO | Option Exercise | 21,369 | $1.43 | $30,558 | Jan 5, 2017 |
| 0001302573 | Chairman & CEO | Award / Grant | 14,000 | — | — | Oct 9, 2016 |
| 0001416792 | Disposition | 2,250 | $32.00 | $72,000 | Sep 1, 2016 | |
| 0001416792 | Award / Grant | 2,250 | — | — | Jun 21, 2016 | |
| PCRX | Award / Grant | 1,488 | — | — | Jun 15, 2016 | |
| 0001416792 | Sale | 1,013 | $19.32 | $19,571 | Jun 7, 2016 | |
| PCRX | Sale | 1,136 | $46.95 | $53,335 | Jun 6, 2016 | |
| PCRX | Option Exercise | 1,000 | $10.81 | $10,810 | Feb 17, 2016 | |
| 0001302573 | Chairman & CEO | Sale | 77 | $21.54 | $1,659 | Jan 6, 2016 |
| PCRX | Sale | 3,000 | $60.00 | $180,000 | Nov 20, 2015 | |
| PCRX | Sale | 3,000 | $60.02 | $180,060 | Aug 17, 2015 | |
| 0001416792 | Sale | 1,454 | $34.63 | $50,352 | Jun 11, 2015 | |
| 0001416792 | Award / Grant | 2,250 | — | — | Jun 4, 2015 | |
| PCRX | Award / Grant | 2,000 | — | — | Jun 3, 2015 | |
| PCRX | Sale | 2,500 | $88.00 | $220,000 | Apr 10, 2015 |